A randomized, double-blind trial of triheptanoin for drug-resistant epilepsy in glucose transporter 1 deficiency syndrome

Striano, P., Auvin, S., Collins, A., Horvath, R., Scheffer, I. E., Tzadok, M., Miller, I., Kay Koenig, M., Lacy, A., Davis, R., Garcia‐Cazorla, A., Saneto, R. P., Brandabur, M., Blair, S., Koutsoukos, T., & De Vivo, D. (2022). A randomized, double‐blind trial of triheptanoin for drug‐resistant epilepsy in glucose transporter 1 deficiency syndrome. Epilepsia, 63(7), 1748–1760. Portico. https://doi.org/10.1111/epi.17263
Authors:
Pasquale Striano
Stéphane Auvin
Abigail Collins
Rita Horvath
Ingrid E. Scheffer
Michal Tzadok
Ian Miller
Mary Kay Koenig
Adrian Lacy
Ronald Davis
Angela Garcia-Cazorla
Russell P. Saneto
Melanie Brandabur
Susan Blair
Tony Koutsoukos
Darryl De Vivo
Affiliated Authors:
Darryl De Vivo
Columbia Affiliation:
Subjects:
Drug Resistant Epilepsy (MeSH)
Epilepsy, Absence (MeSH)
Triglycerides (MeSH)
Effects of Ketogenic Diet on Health (OpenAlex Topic)
Metabolic Disorders and Biochemical Genetics (OpenAlex Topic)
Glycogen Metabolism and Myoclonic Disorders (OpenAlex Topic)
Author Keywords:
diet treatment
drug resistance
epilepsy
glucose transporter 1 deficiency syndrome
triheptanoin
elink
Publication Type:
Article
Unique ID:
10.1111/epi.17263
PMID:
35441706
DOI:
10.1111/epi.17263
Journal:
Epilepsia
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View Web of Science Record
View OpenAlex Record
View PubMed Record

Record Created: